Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2019-11-13
Original SEC Filing: Click here

---

Webplus: CBPO/20191113/6-K/2_EX-99.1/000.htm SEC Original: tm1922569d1_ex99-1.htm
China Biologic Reports Financial Results for the Third Quarter of 2019 BEIJING, China – November 13, 2019 – Third Quarter 2019 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to the Company Diluted net earnings per share · Non-GAAP adjusted net income

---

---

Webplus: CBPO/20191113/6-K/3_EX-99.2/000.htm SEC Original: tm1922569d1_ex99-2.htm
China Biologic Third Quarter 2019 Financial Results Third Quarter 2019 Financial Performance Total sales Total sales for biopharmaceutical products (including plasma products and placenta polypeptide products) increased by 18.8% in RMB terms, or 15.5% in USD terms, to $124.3 million from $107.6 million in the same quarter of 2018, as a result of increased sales of most plasma products including

---

---

Webplus: CBPO/20191113/6-K/1/000.htm SEC Original: tm1922569-1_6k.htm

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2019-11-13CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125